AIM ImmunoTech Inc (NYSE American:AIM)
| 2.05 Delayed Data As of Mar 05 |  -0.04 / -1.91%Today’s Change | 1.60 Today|||52-Week Range 7.11 | +14.53% Year-to-Date |
Latest AIM News | Press Releases
No recent news for AIM ImmunoTech Inc.
Today’s Trading
| Previous close | 2.09 |
| Today’s open | 2.05 |
| Day’s range | 1.96 - 2.09 |
| Volume | 1,697,349 |
| Average volume (3 months) | 2,887,371 |
| Market cap | $105.0M |
Data as of 3:59pm ET, 03/05/2021
Growth & Valuation
| Earnings growth (last year) | +73.22% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -61.85% |
| P/E ratio | 1.4 |
| Price/Sales | 14.15 |
| Price/Book | 2.21 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AGEAgeX Therapeutics In... | -0.01 | -0.45% |
| GLMDGalmed Pharmaceutica... | -0.02 | -0.56% |
| ---- | ||
| DAREDare Bioscience Inc | +0.04 | +2.12% |
Data as of 3:59pm ET, 03/05/2021
Financials
| Next reporting date | April 5, 2021 |
| EPS forecast (this quarter) | -$0.07 |
| Annual revenue (last year) | $140.0K |
| Annual profit (last year) | -$9.5M |
| Net profit margin | -6,809.29% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Ocala, Florida |
Forecasts
